Last updated: 21 May 2024 at 4:25pm EST

Joseph Hagan Net Worth




The estimated Net Worth of Joseph P Hagan is at least $2.22 Million dollars as of 18 January 2024. Mr. Hagan owns over 14,580 units of Regulus Therapeutics Inc stock worth over $87,952 and over the last 9 years he sold RGLS stock worth over $121,789. In addition, he makes $2,014,280 as President, Chief Executive Officer, and Director at Regulus Therapeutics Inc.

Mr. Hagan RGLS stock SEC Form 4 insiders trading

Joseph has made over 21 trades of the Regulus Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 14,580 units of RGLS stock worth $17,350 on 18 January 2024.

The largest trade he's ever made was buying 219,780 units of Regulus Therapeutics Inc stock on 25 July 2017 worth over $200,000. On average, Joseph trades about 10,627 units every 56 days since 2015. As of 18 January 2024 he still owns at least 57,112 units of Regulus Therapeutics Inc stock.

You can see the complete history of Mr. Hagan stock trades at the bottom of the page.





Joseph Hagan biography

Joseph Patrick Hagan serves as President, Chief Executive Officer, Director of the Company. Mr. Hagan previously served as our Chief Operating Officer, principal financial officer and principal accounting officer from January 2016 to May 2017. From June 2011 through December 2015, Mr. Hagan served as the Executive Vice President, Chief Financial Officer and Chief Business Officer of Orexigen Therapeutics, Inc. From May 2009 to June 2011, Mr. Hagan served as Orexigen’s Senior Vice President, Corporate Development, Strategy and Communications. From September 1998 to April 2008,

What is the salary of Joseph Hagan?

As the President, Chief Executive Officer, and Director of Regulus Therapeutics Inc, the total compensation of Joseph Hagan at Regulus Therapeutics Inc is $2,014,280. There are no executives at Regulus Therapeutics Inc getting paid more.



How old is Joseph Hagan?

Joseph Hagan is 51, he's been the President, Chief Executive Officer, and Director of Regulus Therapeutics Inc since 2019. There are 9 older and 4 younger executives at Regulus Therapeutics Inc. The oldest executive at Regulus Therapeutics Inc is David Baltimore, 82, who is the Independent Director.

What's Joseph Hagan's mailing address?

Joseph's mailing address filed with the SEC is C/O REGULUS THERAPEUTICS INC., 4224 CAMPUS POINT COURT #210, SAN DIEGO, CA, 92121.

Insiders trading at Regulus Therapeutics Inc

Over the last 12 years, insiders at Regulus Therapeutics Inc have traded over $78,282,075 worth of Regulus Therapeutics Inc stock and bought 65,288,007 units worth $66,275,578 . The most active insiders traders include Forest Baskett, Scott D Sandell, and Anthony A. Jr. Florence. On average, Regulus Therapeutics Inc executives and independent directors trade stock every 34 days with the average trade being worth of $890,488. The most recent stock trade was executed by Kathryn J Collier on 25 July 2024, trading 4,000 units of RGLS stock currently worth $7,280.



What does Regulus Therapeutics Inc do?

regulus therapeutics inc. (nasdaq:rgls) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting micrornas. regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microrna therapeutics pipeline complemented by a maturing micromarkerssm biomarkers platform and a rich intellectual property estate to retain its leadership in the microrna field. regulus is developing rg-101, a galnac-conjugated anti-mir targeting microrna-122 for the treatment of chronic hepatitis c virus infection, and rg-012, an anti-mir targeting microrna-21 for the treatment of alport syndrome, a life-threatening kidney disease driven by genetic mutations with no approved therapy. in addition, rg-125, a galnac-conjugated anti-mir targeting microrna-103/107 for the treatment of nash in patients with type 2 diabetes/pre-diabetes, has entered phase i clinical development through its strategic alliance with astrazeneca. reg



What does Regulus Therapeutics Inc's logo look like?

Regulus Therapeutics Inc logo

Complete history of Mr. Hagan stock trades at Aurinia Pharmaceuticals Inc, Regulus Therapeutics Inc, and Zosano Pharma Corp

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
18 Jan 2024 Joseph P Hagan
Chief Executive Officer
Sale 14,580 $1.19 $17,350
18 Jan 2024
57,112
12 Jan 2022 Joseph P Hagan
Chief Executive Officer
Buy 100,000 $0.22 $22,000
12 Jan 2022
417,006
17 May 2021 Joseph P Hagan
Chief Executive Officer
Sale 4,186 $0.89 $3,726
17 May 2021
316,292
16 Feb 2021 Joseph P Hagan
Chief Executive Officer
Sale 4,144 $1.72 $7,128
16 Feb 2021
485,756
16 Nov 2020 Joseph P Hagan
Chief Executive Officer
Sale 6,094 $0.52 $3,169
16 Nov 2020
215,994
14 Aug 2020 Joseph P Hagan
Chief Executive Officer
Sale 4,245 $0.60 $2,547
14 Aug 2020
222,088
15 May 2020 Joseph P Hagan
Chief Executive Officer
Sale 4,426 $0.63 $2,788
15 May 2020
226,333
18 Feb 2020 Joseph P Hagan
Chief Executive Officer
Sale 4,324 $0.83 $3,589
18 Feb 2020
230,759
2 Jan 2020 Joseph P Hagan
Chief Executive Officer
Sale 8,345 $0.97 $8,095
2 Jan 2020
235,083
14 Nov 2019 Joseph P Hagan
Chief Executive Officer
Sale 5,838 $0.64 $3,736
14 Nov 2019
243,428
1 Oct 2019 Joseph P Hagan
Chief Executive Officer
Sale 8,743 $0.68 $5,945
1 Oct 2019
249,266
15 Aug 2019 Joseph P Hagan
Chief Executive Officer
Sale 4,375 $0.55 $2,406
15 Aug 2019
258,009
1 Jul 2019 Joseph P Hagan
Chief Executive Officer
Sale 5,783 $1.31 $7,576
1 Jul 2019
262,384
14 May 2019 Joseph P Hagan
Chief Executive Officer
Sale 39,352 $1.22 $48,009
14 May 2019
268,167
7 May 2019 Joseph P Hagan
Chief Executive Officer
Buy 33,194 $1.08 $35,850
7 May 2019
64,542
1 Apr 2019 Joseph P Hagan
Chief Executive Officer
Sale 5,842 $0.98 $5,725
1 Apr 2019
31,348
25 Jul 2017 Joseph P Hagan
Chief Executive Officer
Buy 219,780 $0.91 $200,000
25 Jul 2017
241,297
3 Mar 2016 Joseph P Hagan
Chief Executive Officer
Buy 10,000 $7.19 $71,900
3 Mar 2016
10,000
3 Mar 2016 Joseph P Hagan
Chief Executive Officer
Buy 10,000 $7.19 $71,900
3 Mar 2016
10,000
18 May 2023 Joseph P Hagan
Director
Option 8,733 $10.74 $93,792
18 May 2023
12,233
3 Jan 2022 Joseph P Hagan
Director
Option 40,000 $5.08 $203,200
3 Jan 2022
43,500


Regulus Therapeutics Inc executives and stock owners

Regulus Therapeutics Inc executives and other stock owners filed with the SEC include: